Original ResearchImpact of type of maternal cardiovascular disease on pregnancy outcomes among women managed in a multidisciplinary cardio-obstetrics program
Introduction
Cardiovascular disease (CVD) complicates up to 4% of pregnancies in the United States and is the leading cause of maternal deaths related to hypertension and preeclampsia.1,2 Over the past decade, the number of women with congenital heart disease (CHD) delivering children has increased largely because of the advances in pediatric care.3,4 The prevalence of acquired cardiovascular disease (particularly coronary artery disease) is also increasing among reproductive-aged women owing to the higher rates of obesity, hypertension, and diabetes.5 Because of the increasing frequency and impact of CVD in pregnant women, the American College of Cardiology, the American Heart Association (AHA), the European Society of Cardiology, and the Canadian Cardiovascular Society have all established guidelines for the management of CVD during pregnancy,4, 5, 6, 7 highlighting the importance of multidisciplinary care for pregnant women with CVD.7
Our cardio-obstetrics program was conceived and developed at the Lehigh Valley Health Network (LVHN) in 2010 before the establishment of the above guidelines. We previously published our initial 4 year referral patterns as a quality improvement study and included all women referred to the program (173), both with and without documented CVD.8 The objective of this study was to compare the pregnancy outcomes among women with different CVD types (CHD, acquired heart disease [AHD], arrhythmias or channelopathies, or aortopathies) who were followed in this multidisciplinary program since 2010 and who had diagnostic confirmation of CVD. We hypothesized that the cardiac and obstetrical outcomes among women with preexisting CVD would vary depending on the CVD category.
Section snippets
Materials and Methods
This was a retrospective cohort study of patients with diagnostic evidence of structural or functional CVD who were seen as part of the cardio-obstetrics program at LVHN from its inception in March 2010 to November 2019. The LVHN is a 1700 bed network of 8 hospital campuses in eastern Pennsylvania. LVHN is a branch medical campus affiliate of the University of South Florida Morsani College of Medicine and is a level IV Regional Perinatal Health Center with approximately 4700 deliveries per
Results
There were 577 visits by women who were seen as part of the cardio-obstetrics program between March 2010 and November 2019; 324 were excluded primarily because of symptoms without diagnostic evidence of structural or functional CVD, giving a final cohort of 232 women with 253 pregnancies who were followed in the program during the study period (Figure). There were 2 sets of twin gestations, 17 women with 2 pregnancies, and 2 women with 3 pregnancies. For the 19 women with more than 1 pregnancy
Principal findings of the study
Overall, we found that women whose pregnancies were complicated by CVD had favorable outcomes when managed in a specialized, multidisciplinary program with low rates of preterm birth, growth restriction, and serious cardiac events. We also found that women with AHD had an increased risk for preeclampsia (explained by chronic hypertension and obesity), preterm birth (primarily owing to the increased rates of preeclampsia), and a trend toward an increased rate of cesarean deliveries when compared
References (27)
- et al.
Pregnancy outcomes in women with heart disease: The CARPREG II Study
J Am Coll Cardiol
(2018) - et al.
Preventing complications in pregnant women with cardiac disease
J Am Coll Cardiol
(2020) - et al.
The fourth trimester: a critical transition period with unmet maternal health needs
Am J Obstet Gynecol
(2017) - et al.
Preconception counseling in women with diabetes by primary care providers and perceived barriers to initiating this discussion
Endocr Pract
(2020) - et al.
Cardiovascular care for pregnant women with cardiovascular disease
J Am Coll Cardiol
(2020) - et al.
Severe cardiovascular morbidity inwomen with hypertensive diseases during delivery hospitalization
Am J Obstet Gynecol
(2019) - et al.
Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy
Am J Obstet Gynecol
(2015) - et al.
Medical and obstetric outcomes among pregnant women with congenital heart disease
Obstet Gynecol
(2015) Cardiovascular management in pregnancy: congenital heart disease
Circulation
(2014)- et al.
Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association
Circulation
(2011)
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)
Eur Heart J
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Eur Heart J
Novel collaborative cardiology and maternal fetal medicine practice—experience at the heart and pregnancy program
J Matern Fetal Neonatal Med
Cited by (0)
The authors report no conflict of interest.
The authors report no funding sources.